Aims & Scope:
Current Computer-Aided Drug Design (CCADD) is an interdisciplinary journal (or theme/initiative) dedicated to publishing high-quality research at the intersection of computational chemistry, artificial intelligence, and pharmaceutical sciences. The journal aims to accelerate drug discovery by integrating traditional computer-aided drug design (CADD) techniques with cutting-edge artificial intelligence-driven drug design (AIDD) methodologies.
Topics of interest include, but are not limited to:
- AI/ML algorithms for hit identification, optimization, and target prediction
- Deep learning, generative models for de novo drug design
- Multi-omics integration, pharmacogenomics and AI for target identification
- AI-enhanced molecular dynamics and binding free energy calculations
- Structure- and ligand-based drug design
- AI-assisted repurposing of existing drugs and natural products
Current Computer-Aided Drug Design is an international, peer-reviewed journal in all aspects of drug design based on computational techniques, published bimonthly (print & online) by Bentham Science Publishers.
